Sign in
4

Changes in Ownership

Intellia Therapeutics, Inc. Filed Acc 0001209191-21-024889

President and CEO sold 38,209 shares at an average $83.64 ($3,195,661)

  • President and CEO acquired 71,041 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
LEONARD JOHN M President and CEO 2021-04-01 Option exercise +45,000 $14.58 $656,100 705,536 D: show line 1 in the form
LEONARD JOHN M President and CEO 2021-04-01 Sale −24,314 $84.00 $2,042,376 681,222 D: show line 2 in the form
LEONARD JOHN M President and CEO 2021-04-01 Option exercise +26,041 $13.40 $348,949 707,263 D: show line 3 in the form
LEONARD JOHN M President and CEO 2021-04-01 Sale −13,895 $83.00 $1,153,285 693,368 D: show line 4 in the form
Open-market sales · 38,209 sh · avg $83.64 · $3,195,661

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
LEONARD JOHN M President and CEO 2021-04-01 Option exercise · Stock Option (right to buy) −45,000 155,000 D: show line 5 in the form
LEONARD JOHN M President and CEO 2021-04-01 Option exercise · Stock Option (right to buy) −26,041 273,959 D: show line 6 in the form
Loading xslF345X03/doc4.xml…